piracetam has been researched along with Anoxia-Ischemia, Brain in 7 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this study was to determine the efficacy and safety of levetiracetam in treatment of neonatal seizures due to hypoxic ischemic encephalopathy." | 7.85 | Levetiracetam for the Treatment of Seizures in Neonatal Hypoxic Ischemic Encephalopathy. ( Schapiro, M; Thomas, C; Venkatesan, C; Young, S, 2017) |
| "The objective of this study was to determine the efficacy and safety of levetiracetam in treatment of neonatal seizures due to hypoxic ischemic encephalopathy." | 3.85 | Levetiracetam for the Treatment of Seizures in Neonatal Hypoxic Ischemic Encephalopathy. ( Schapiro, M; Thomas, C; Venkatesan, C; Young, S, 2017) |
| "Levetiracetam is a new-generation antiepileptic drug that has begun to be used in the treatment of epilepsy." | 1.40 | Neuroprotective effect of levetiracetam on hypoxic ischemic brain injury in neonatal rats. ( Balci, S; Beydagi, H; Celik, Y; Erdogan, S; Komur, M; Okuyaz, C; Polat, A; Resitoglu, B; Tamer, L, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Komur, M | 2 |
| Okuyaz, C | 2 |
| Celik, Y | 2 |
| Resitoglu, B | 2 |
| Polat, A | 2 |
| Balci, S | 1 |
| Tamer, L | 1 |
| Erdogan, S | 3 |
| Beydagi, H | 2 |
| Griesmaier, E | 1 |
| Stock, K | 1 |
| Medek, K | 1 |
| Stanika, RI | 1 |
| Obermair, GJ | 1 |
| Posod, A | 1 |
| Wegleiter, K | 1 |
| Urbanek, M | 1 |
| Kiechl-Kohlendorfer, U | 1 |
| Venkatesan, C | 1 |
| Young, S | 1 |
| Schapiro, M | 1 |
| Thomas, C | 1 |
| Arslankoylu, AE | 1 |
| Cilio, MR | 1 |
| Ferriero, DM | 1 |
| Kilicdag, H | 1 |
| Daglıoglu, K | 1 |
| Guzel, A | 1 |
| Sencar, L | 1 |
| Polat, S | 1 |
| Zorludemir, S | 1 |
| He, Z | 1 |
| Liao, Y | 1 |
| Zheng, M | 1 |
| Zeng, FD | 1 |
| Guo, LJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Use of Melatonin for Neuroprotection in Term Infants With Hypoxic-ischaemic Encephalopathy[NCT03806816] | 100 participants (Anticipated) | Interventional | 2018-12-13 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for piracetam and Anoxia-Ischemia, Brain
| Article | Year |
|---|---|
Synergistic neuroprotective therapies with hypothermia.
Topics: Acetylcysteine; Anticonvulsants; Body Temperature; Cannabinoids; Combined Modality Therapy; Erythrop | 2010 |
6 other studies available for piracetam and Anoxia-Ischemia, Brain
| Article | Year |
|---|---|
Neuroprotective effect of levetiracetam on hypoxic ischemic brain injury in neonatal rats.
Topics: Animals; Animals, Newborn; Apoptosis; Brain Injuries; Caspase 3; Catalase; Cell Count; Dose-Response | 2014 |
Levetiracetam increases neonatal hypoxic-ischemic brain injury under normothermic, but not hypothermic conditions.
Topics: Animals; Apoptosis Inducing Factor; Caspase 3; Cell Count; Cell Death; Cells, Cultured; Cerebral Cor | 2014 |
Levetiracetam for the Treatment of Seizures in Neonatal Hypoxic Ischemic Encephalopathy.
Topics: Adult; Anticonvulsants; Female; Follow-Up Studies; Humans; Hypothermia, Induced; Hypoxia-Ischemia, B | 2017 |
Is levetiracetam neuroprotective in neonatal rats with hypoxic ischemic brain injury?
Topics: Animals; Animals, Newborn; Apoptosis; Brain; Brain Injuries; Disease Models, Animal; Dose-Response R | 2016 |
The effect of levetiracetam on neuronal apoptosis in neonatal rat model of hypoxic ischemic brain injury.
Topics: Analysis of Variance; Animals; Animals, Newborn; Apoptosis; Cerebral Cortex; Hippocampus; Histologic | 2013 |
Piracetam improves cognitive deficits caused by chronic cerebral hypoperfusion in rats.
Topics: Animals; bcl-2-Associated X Protein; Cognition Disorders; Drug Evaluation, Preclinical; Electrophysi | 2008 |